Unclassified · Medical Literature

[Articles] Efficacy and safety of duvakitug in patients with Crohn's disease (RELIEVE UCCD): a phase 2b, randomised, placebo-controlled trial

Authors
Vipul Jairath, Jaroslaw Kierkuś, George Aaron Duvall, Silvio Danese, Bruce E Sands, Bogdan Ratiu-Duma, Rajendra Singh, Phillip Levine, Hadas Barkay, Nicholas Gross, Ken Abrams, Walter Reinisch
Journal
The Lancet Gastroenterology & Hepatology
Publication date
2026-07-16
Source
rss_lancet_gas
Original record ID
210200
Summary status
error
Analysis status
error
Original last updated
2026-08-10T07:01:48.000Z

Open original source

Abstract

Duvakitug showed significant evidence for endoscopic response versus placebo in patients with moderately to severely active Crohn's disease, with no safety concerns identified.